Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?

被引:93
|
作者
Calio, Brian P. [1 ]
Sidana, Abhinav [1 ,6 ]
Sugano, Dordaneh [1 ]
Gaur, Sonia [2 ]
Maruf, Mahir [1 ]
Jain, Amit L. [1 ]
Merino, Maria J. [3 ]
Choyke, Peter L. [2 ]
Wood, Bradford J. [4 ,5 ]
Pinto, Peter A. [1 ]
Turkbey, Baris [2 ]
机构
[1] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA
[3] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[4] NCI, Ctr Intervent Oncol, NIH, Bethesda, MD 20892 USA
[5] NIH, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA
[6] Univ Cincinnati, Coll Med, Div Urol, Cincinnati, OH USA
来源
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词
prostatic neoplasms; image-guided biopsy; neoplasm grading; pathology; surgical; risk; SYSTEMATIC BIOPSY; CANCER-DETECTION; GLEASON SCORES; SPECIMENS; DIAGNOSIS; ACCURATE; GUIDANCE;
D O I
10.1016/j.juro.2017.10.048
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We sought to determine whether saturation of the index lesion during magnetic resonance imaging-transrectal ultrasound fusion guided biopsy would decrease the rate of pathological upgrading from biopsy to radical prostatectomy. Materials and Methods: We analyzed a prospectively maintained, single institution database for patients who underwent fusion and systematic biopsy followed by radical prostatectomy in 2010 to 2016. Index lesion was defined as the lesion with largest diameter on T2-weighted magnetic resonance imaging. In patients with a saturated index lesion transrectal fusion biopsy targets were obtained at 6 mm intervals along the long axis of the index lesion. In patients with a nonsaturated index lesion only 1 target was obtained from the lesion. Gleason 6, 7 and 8-10 were defined as low, intermediate and high risk, respectively. Results: Included in the study were 208 consecutive patients, including 86 with a saturated and 122 with a nonsaturated lesion. Median patient age was 62.0 years (IQR 10.0) and median prostate specific antigen was 7.1 ng/ml (IQR 8.0). The median number of biopsy cores per index lesion was higher in the saturated lesion group (4 vs 2, p < 0.001). The risk category upgrade rate from systematic only, fusion only, and combined fusion and systematic biopsy results to prostatectomy was 40.9%, 23.6% and 13.8%, respectively. The risk category upgrade from combined fusion and systematic biopsy results was lower in the saturated than in the nonsaturated lesion group (7% vs 18%, p = 0.021). There was no difference in the upgrade rate based on systematic biopsy between the 2 groups. However, fusion biopsy results were significantly less upgraded in the saturated lesion group (Gleason upgrade 20.9% vs 36.9%, p = 0.014 and risk category upgrade 14% vs 30.3%, p = 0.006). Conclusions: Our results demonstrate that saturation of the index lesion significantly decreases the risk of upgrading on radical prostatectomy by minimizing the impact of tumor heterogeneity.
引用
收藏
页码:976 / 981
页数:6
相关论文
共 50 条
  • [2] Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help? EDITORIAL COMMENT
    Marks, Leonard S.
    JOURNAL OF UROLOGY, 2018, 199 (04): : 981 - 982
  • [3] Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of the Prostate-An Update
    Das, Chandan J.
    Razik, Abdul
    Sharma, Sanjay
    SEMINARS IN ROENTGENOLOGY, 2018, 53 (03) : 219 - 226
  • [4] Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy
    Muller, Berrend G.
    Kaushal, Aradhana
    Sankineni, Sandeep
    Lita, Elena
    Hoang, Anthony N.
    George, Arvin K.
    Rais-Bahrami, Soroush
    Kruecker, Jochen
    Yan, Pingkun
    Xu, Sheng
    de la Rosette, Jean J.
    Merino, Maria J.
    Wood, Bradford J.
    Pinto, Peter A.
    Choyke, Peter L.
    Turkbey, Baris
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (10) : 425.e1 - 425.e6
  • [5] PROPENSITY SCORE ANALYSIS OF PATHOLOGICAL OUTCOME AT RADICAL PROSTATECTOMY FOR MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND FUSION PROSTATE BIOPSY VERSUS UNTARGETED EXTENDED TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY
    Arora, Hans
    Elshafei, Ahmed
    Nyame, Yaw
    Sun, Daniel
    Liang, Helen
    Yerram, Nitin
    Greene, Daniel
    Grimberg, Dominic
    Gupta, Karishma
    Agrawal, Shree
    Isharwal, Sudhir
    Babbar, Paurush
    Sun, Andrew
    Fareed, Khaled
    Gong, Michael
    Berglund, Ryan
    Klein, Eric
    Stephenson, Andrew
    Purysko, Andrei
    Jones, J. Stephen
    JOURNAL OF UROLOGY, 2017, 197 (04): : E488 - E489
  • [6] Multiparametric magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy with elastic fusion: a prospective study in the Chinese population
    Ma, Wai Kit
    Yiu, Ming Kwong
    Lam, Angus Kc
    Lai, Andrew Sh
    Lam, Alan Sc
    Yip, Lawrance Kc
    Wong, Charles Kw
    Lai, Terence Ct
    Tsang, Chiu Fung
    Lam, Wayne P.
    Ho, Brian Sh
    Ng, Ada Tl
    Tsu, James Hl
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 206 - 206
  • [7] Risk of upgrading from prostate biopsy to radical prostatectomy pathology: Is magnetic resonance imaging-guided biopsy more accurate?
    Xu, Ning
    Wu, Yu-Peng
    Li, Xiao-Dong
    Lin, Min-Yi
    Zheng, Qing-Shui
    Chen, Shao-Hao
    Li, Jun-Feng
    Wei, Yong
    Xue, Xue-Yi
    JOURNAL OF CANCER, 2018, 9 (19): : 3634 - 3639
  • [8] Visibility of prostate cancer on transrectal ultrasound during fusion with multiparametric magnetic resonance imaging for biopsy
    van de Ven, Wendy J. M.
    Sedelaar, J. P. Michiel
    van der Leest, Marloes M. G.
    Hulsbergen-van de Kaa, Christina A.
    Barentsz, Jelle O.
    Futterer, Jurgen J.
    Huisman, Henkjan J.
    CLINICAL IMAGING, 2016, 40 (04) : 745 - 750
  • [9] Prostate Cancer Risk Assessment in Biopsy-naive Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy
    Mannaerts, Christophe K.
    Gayet, Maudy
    Verbeek, Jan F.
    Engelbrecht, Marc R. W.
    Savci-Heijink, C. Dilara
    Jager, Gerrit J.
    Gielens, Maaike P. M.
    van der Linden, Hans
    Beerlage, Harrie P.
    de Reijke, Theo M.
    Wijkstra, Hessel
    Roobol, Monique J.
    EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (02): : 109 - 117
  • [10] COMPARISON OF MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND FUSION PROSTATE BIOPSY WITH STANDARD SYSTEMATIC BIOPSY: A SINGLE CENTER EXPERIENCE
    Koparal, Murat Yavuz
    Bulut, Ender Cem
    Cetin, Serhat
    Cosar, Ugur
    Budak, Firat Caglar
    Ucar, Murat
    Tokgoz, Nil
    Senturk, Aykut Bugra
    Sen, Ilker
    Sozen, Tevfik Sinan
    ARCHIVOS ESPANOLES DE UROLOGIA, 2021, 74 (08): : 790 - 795